<?xml version="1.0" encoding="UTF-8"?>
<p>SARS‐CoV‐2 belongs to lineage B of the 
 <italic>β‐CoVs</italic>, a subgroup of Sarbecovirus, which contains a positive‐sense single‐stranded RNA as the hereditary substance and is wrapped in a nucleocapsid protein in the core region and a peripheral envelope consisting of the spike protein, e
 <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3116%26familyId=1034%26familyType=OTHER" xmlns:xlink="http://www.w3.org/1999/xlink">nvelope protein</ext-link>, and 
 <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3117%26familyId=1034%26familyType=OTHER" xmlns:xlink="http://www.w3.org/1999/xlink">membrane protein</ext-link> (Figure 
 <xref rid="bph15092-fig-0001" ref-type="fig">1a</xref>) (Chan et al., 
 <xref rid="bph15092-bib-0016" ref-type="ref">2020</xref>). The genomic organization of SARS‐CoV‐2 was consistent with a single‐stranded positive‐sense RNA, which contains 5′‐methylated caps and 3′‐polyadenylated tails and is arranged in the following order: 5′ end; replicase ORF1a/b; spike (S); envelope (E); membrane (M); 
 <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3121" xmlns:xlink="http://www.w3.org/1999/xlink">nucleoprotein</ext-link> (N); accessory proteins such as ORF 3, 6, 7a, 7b, 8 and 9b; and the 3′ end (Figure 
 <xref rid="bph15092-fig-0001" ref-type="fig">1b</xref>). Phylogenetic analysis studies showed that SARS‐CoV‐2 has the closest relationship with bat‐derived SARS‐CoV but is not completely identical to SARS‐CoV (approximately 79% identity) or MERS‐CoV (approaching 50% identity) (Paraskevis et al., 
 <xref rid="bph15092-bib-0074" ref-type="ref">2020</xref>).
</p>
